NCT01383421View on ClinicalTrials.gov

Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)

CompletedOBSERVATIONAL
Enrollment

1,036

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Rheumatoid Arthritis
All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01383421 - Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP) | Biotech Hunter | Biotech Hunter